Valuation (14%) |
Company | Industry |
---|---|---|
P/E Ratio (TTM) | -15.84 | 51.33 |
PEG Ratio (TTM) | 5.86 | -8.70 |
P/S Ratio (TTM) | 33.50 | 14.00 |
P/B Ratio (TTM) | 7.68 | 12.83 |
P/FCF Ratio (TTM) | -24.62 | 45.79 |
Price to 5YR AVG Earnings Ratio | N/A | 70.02 |
Price to 5YR AVG FCF Ratio | N/A | 76.37 |
Profitability (0%) |
Company | Industry |
---|---|---|
ROA (TTM) | -40.70% | -2.47% |
ROE (TTM) | -100.14% | 6.60% |
Net Profit Margin (TTM) | -195.65% | 3.51% |
ROIC 5YR AVG | N/A | 4.51% |
Growth (25%) |
4QTR AVG | 3YR AVG | 5YR AVG |
---|---|---|---|
EPS | -7.51% | 20.29% | N/A |
Revenue | 16.15% | 59.75% | N/A |
Net Income | -19.41% | -22.46% | N/A |
Cash Flow | -4.37% | -28.53% | N/A |
Health (63%) |
Company | Industry |
---|---|---|
Current Ratio (TTM) | 8.77 | 1.85 |
Quick Ratio (TTM) | 8.77 | 2.10 |
D/E Ratio (TTM) | 0.02 | 0.53 |
Interest Coverage (TTM) | -3.53 | 10.65 |
Piotroski F-Score | 3 | 6 |
Altman Z-Score | 23.46 | 9.15 |
LTL to 5YR AVG FCF | N/A | 3.41 |
Shares Outstanding Growth 5YR AVG | N/A | 57.08% |